plasminogen activator inhibitor
基本解釋
- 纖溶酶原激活物抑制劑
英漢例句
- The high-phenol group also experienced a greater drop in the activity of another clot promoter, plasminogen activator inhibitor-1.
高酚早餐組另一血栓促進(jìn)因子——纖維蛋白溶酶原活化抑制因子-1的活性也呈現(xiàn)顯著降低。 - Objective To study the relationship of plasminogen activator inhibitor type 1(PAI 1) to platelet activity in elderly patients with unstable angina pectoris(UAP).
目的探討老年不穩(wěn)定型心絞痛(UAP)與纖溶酶原激活物抑制劑1型(PAI 1)及血小板活化功能的臨床意義。 - Plasminogen activator inhibitor-1 (PAI-1) is one of the important components of the plasma fibrinolytic system and plays an key role in maintaining its stability.
纖溶酶原激活物抑制物1(PAI-1)是血漿纖維蛋白溶解系統(tǒng)的重要組成物之一,對維持血漿纖溶系統(tǒng)的穩(wěn)定起重要作用。
雙語例句
詞組短語
- human plasminogen -activator inhibitor type 人纖溶酶原激活物抑制物
- activator plasminogen activator inhibitor 纖溶酶原激活劑及其抑制物
- human plasminogen activator inhibitor 人pai
- plasminogen activator inhibitor activity 血漿纖溶酶原激活物抑制劑
- plasminogen activator in inhibitor 纖溶酶原激活劑
短語
專業(yè)釋義
- 纖溶酶原激活劑抑制劑
It has been reported that fibrinolytic dysfunction caused by variation in the activity and concentration of tissue plasminogen activator (t - PA ) and plasminogen activator inhibitor - 1 ( PAI -1) seems to be related to atherosclerosis and thrombosis.
研究表明,血液中組織型纖溶酶原激活劑(t-PA)和纖溶酶原激活劑抑制劑-1(PAI-1)活性或含量的變化導(dǎo)致的纖溶活性減低與冠狀動脈粥樣硬化及血栓形成和延展有關(guān)。 - 纖溶酶原抑制劑
- 纖溶酶原活化物抑制劑
Objectives: To find out the effects of estrogen and progestin on the activity and mRNA expression of tissue-type plasminogen activator(tPA) and plasminogen activator inhibitor -1 (PAI-1) in human umbilical vein endothelial cells (HUVEC).
目的:觀察雌孕激素對人臍靜脈內(nèi)皮細(xì)胞(HUVEC)組織型纖溶酶原激活劑(tPA)、纖溶酶原活化物抑制劑-1(PAI-1)的活性及其基因表達(dá)的影響。生物學(xué)
- 纖溶酶原活化物抑制劑
- 纖溶酶原激活物抑制劑
- 纖溶酶原激活物抑制劑